
Sunrun, the nation’s largest residential solar company, said on Monday that it was acquiring a leading competitor, Vivint Solar, to form one of the world’s largest providers of solar equipment.
If approved, the all-stock deal would create a company with about 500,000 customers, Sunrun said in a statement. Board members of both companies unanimously approved the deal, it said.
Sunrun said the deal had an enterprise value — that is, including the assumption of debt — of $3.2 billion.
“There’s a mandate to continue to lower costs,” Lynn Jurich, Sunrun’s chief executive and co-founder, said on Tuesday during a conference call about the deal. “The businesses are so complimentary. So for us this was the right time to pursue this.”
Sunrun, based in San Francisco, and Vivint, based in Lehi, Utah, have held two of the top three positions in the residential solar market along with Tesla. Sunrun, founded in 2007, overtook Tesla as the nation’s leading residential solar company in 2018. In addition to residential solar panels, Sunrun and Vivint sell residential battery systems.
Full Content: New York Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas